ENTRY       D08290                      Drug
NAME        Oblimersen (INN)
FORMULA     C172H221N62O91P17S17
EXACT_MASS  5680.5363
MOL_WEIGHT  5684.6149
REMARK      ATC code: L01XX36
            Chemical structure group: DG00728
EFFICACY    Antineoplastic, Translation inhibitor, Bcl-2 inhibitor
  TYPE      Antisense oligonucleotide
COMMENT     Cytostatic, cytostaticum
TARGET      BCL2 [HSA:596] [KO:K02161] (mRNA)
  PATHWAY   hsa04210(596)  Apoptosis
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01X OTHER ANTINEOPLASTIC AGENTS
                L01XX Other antineoplastic agents
                 L01XX36 Oblimersen
                  D08290  Oblimersen (INN)
            Target-based classification of drugs [BR:br08310]
             Not elsewhere classified
              Cellular process
               Apoptosis
                BCL2
                 D08290  Oblimersen (INN)
DBLINKS     CAS: 190977-41-4
            PubChem: 96024977
///
